Last reviewed · How we verify
Stress & Social Cognition in BPD (part 2) (SOKO-2)
The investigators will examine how a combination of pharmacological mineralocorticoid receptor (MR) stimulation and psychosocial stress will influence prosocial behavior in patients with Borderline Personality Disorder (BPD) compared to healthy controls (HC).
Details
| Lead sponsor | Charite University, Berlin, Germany |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 240 |
| Start date | Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Mar 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Borderline Personality Disorder
Interventions
- Fludrocortisone
- Placebo
- Trier Social Stress Test (TSST)
- Placebo Trier Social Stress Test (P-TSST)
Countries
Germany